The CD5 lymphocyte surface glycoprotein is a coreceptor involved in the mod
ulation of antigen-specific receptor-mediated activation and differentiatio
n signals. Although first considered a costimulatory molecule in mature per
ipheral T cells, recent studies of CD5(-/-) mice have opened the possibilit
y that CD5 may also mediate inhibitory signals that attenuate TCR/CD3- and
BCR-mediated triggering in thymocytes and a subgroup of B cells (B-1a cells
), respectively. The ultimate molecular basis for these differential modula
tory properties of CD5, depending on the context of lymphocyte subset and d
ifferentiation stage, are presently unknown and are an issue of current int
ensive investigation. Here, we review recent reports, both contradictory an
d complementary, focused on CD5-mediated molecular intracellular signaling
events that could provide the basis for its immunomodulatory properties.